We need more clarity on what we’ll do with our huge surplus, and when. Sure, keep some for boosters, variants etc.
But we’re holding onto tens of millions of doses that we haven’t even authorized for use - and may never. reuters.com/article/us-hea…
What would I like to see?
Right now we’re sending out ~16 million doses weekly. That number will grow when more J&J is added at the end of the month and as capacity for the others picks up.
What if we contribute a small % of our weekly allocation to the global community?
Let’s start with 3% weekly in April.
That would be 480k doses per week. Under 2 million the whole month.
Now increase by 1% for May, donating 4% of our weekly supply. That’s 640k doses a week...
Up to 5% in June, for a total of 800k doses/week (3.4 million for the month).
The total we’d donate in that whole time would be less than 1 weeks worth of our supply.
And almost certainly wouldn’t impact the President’s goal of getting enough vaccine for everyone by May 31.
Once we have vaccinated everyone who wants one here, let’s start donating a bigger portion of our incoming supply (10%!) while maintaining the stockpile we need for future uncertainty.
But we absolutely don’t need to sit on hundreds of millions of doses ‘just in case’.
Getting the rest of the world vaccinated is in our best interest.
It would help reestablish the US as a leader in global health.
And it would also help prevent the development and spread of variants. Plus it’s bring huge economic benefits as well!
This ⤵️ examined the inequities of the global #COVID19 vaccine rollout. Wealthy nations need to help the rest of the world get vaccinated - not just for moral and humanitarian reasons, but also to tamp down variants and soften the global economic impact.
This ⤵️ outlined the precarious place we’re at in the pandemic. The next phase will depend on vaccines, variants, and how well we adhere to public health measures.
The recent lifting of restrictions & mask mandates may unnecessarily prolong the pandemic. link.medium.com/wCfDk8eCpeb
Learning the lessons from disease outbreaks is critical to improving response.
In our commentary for @TheLancet, @syramadad and I reflect on the lessons the U.S. learned responding to Ebola and how they could’ve better informed our #COVID19 response. 🧵
This graphic from @TheEconomist shows a breakdown of doses ordered per adult worldwide, revealing a massive imbalance. Many countries have ordered way more vaccine than people eligible to receive it.
“Half of the world’s supply has been reserved for just 15% of its population”
And this @nytimes graphic tracking vaccination rates by continent shows how inequitable the rollout has been so far.
In North America, ~10 doses have been administered for every 100 people.
That’s almost 5x the rate of South America and 50x that of Africa.
Since the vaccine rollout 2 weeks ago, way more people have been diagnosed with #COVID19 than were vaccinated against it.
The stated goal of vaccinating 20 million by years end definitely won’t happen. In fact, at this rate, it would take years to vaccinate enough Americans...🧵
For months we’ve been concerned that the last-mile logistics of the vaccine rollout weren’t as well-coordinated as the amazing science that got us vaccines in record time.
And now that vaccines are here, we’re seeing massive delays in getting vaccine out and injected into arms.
Creating a safe vaccine in record time is undoubtedly hard.
But quickly getting it out - all across the country, in vials at subarctic temperatures, to facilities big and small, and ultimately into peoples’ arms in a coordinated fashion - is arguably harder.